Shire Pays $48M To End Adderall Supply Suit

Law360, New York (February 8, 2013, 2:23 PM EST) -- Shire LLC will pay $48 million to settle allegations in New York federal court that it shorted Impax Laboratories Inc. on supplies of a generic version of increasingly popular attention deficit hyperactivity disorder drug Adderall XR, the companies announced Friday.

As part of the deal, the drugmakers entered into an amended licensing agreement that runs through September 2014 and calls for California-based Impax to pay a share of profits from Adderall sales to U.K.-based Shire. The settlement comes more than two years after Impax sued Shire,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.